JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

Search

Integra LifeSciences Holdings Corp

Slēgts

SektorsVeselības aprūpe

10.82 -1.73

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

10.8

Max

11.11

Galvenie mērījumi

By Trading Economics

Ienākumi

479M

-5.4M

Pārdošana

-14M

402M

Peļņas marža

-1.344

Darbinieki

4,396

EBITDA

526M

54M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+17.33% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 24. febr.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-386M

869M

Iepriekšējā atvēršanas cena

12.55

Iepriekšējā slēgšanas cena

10.82

Ziņu noskaņojums

By Acuity

78%

22%

324 / 352 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 5. febr. 23:57 UTC

Peļņas

Naver Has Record Year Despite Weaker Final Quarter

2026. g. 5. febr. 23:45 UTC

Karstas akcijas

Stocks to Watch: Amazon, Coty, Gen Digital, Roblox

2026. g. 5. febr. 22:26 UTC

Peļņas

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9% -- Update

2026. g. 5. febr. 22:00 UTC

Peļņas

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9%

2026. g. 5. febr. 23:47 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 5. febr. 23:47 UTC

Tirgus saruna

Nikkei May Fall After U.S. Tech Stock Drops -- Market Talk

2026. g. 5. febr. 23:43 UTC

Tirgus saruna

Gold Falls on Spillover Impact From Cryptocurrencies' Selloff -- Market Talk

2026. g. 5. febr. 23:37 UTC

Tirgus saruna

Glencore Shares Look Cheap After Failed Takeover Talks -- Market Talk

2026. g. 5. febr. 23:20 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 5th Update

2026. g. 5. febr. 23:11 UTC

Tirgus saruna

Amazon CEO Confident in Return on $200B Investment -- Market Talk

2026. g. 5. febr. 23:09 UTC

Peļņas

Naver 2025 Net KRW1.820T Vs. Net KRW1.932T >035420.SE

2026. g. 5. febr. 23:08 UTC

Peļņas

Naver 2025 Oper Pft KRW2.208T Vs. Pft KRW1.979T >035420.SE

2026. g. 5. febr. 23:07 UTC

Peļņas

Naver 2025 Rev KRW12.035T Vs. KRW10.738T >035420.SE

2026. g. 5. febr. 23:03 UTC

Tirgus saruna
Peļņas

REA's Update Looks Negative Despite A$200M Buyback -- Market Talk

2026. g. 5. febr. 23:03 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Bitcoin Booster's $12 Billion Loss Headlines Crypto's Worst Day Since 2022 Crash -- WSJ

2026. g. 5. febr. 23:00 UTC

Peļņas

Naver 4Q Net Profit Missed FactSet-Compiled Consensus

2026. g. 5. febr. 23:00 UTC

Peļņas

Naver 4Q Net KRW164.60B Vs. Net KRW514.00B >035420.SE

2026. g. 5. febr. 22:59 UTC

Peļņas

Naver 4Q Oper Pft KRW610.60B Vs. Pft KRW542.00B >035420.SE

2026. g. 5. febr. 22:59 UTC

Peļņas

Naver 4Q Rev KRW3.195T Vs. KRW2.886T >035420.SE

2026. g. 5. febr. 22:52 UTC

Peļņas

Alphabet Stock Is Taking a Hit After Strong Earnings. Don't Panic. -- Barrons.com

2026. g. 5. febr. 22:45 UTC

Peļņas

Amazon Stock Falls Sharply on Earnings. Spending Continues to Soar. -- Barrons.com

2026. g. 5. febr. 22:37 UTC

Tirgus saruna

Woolworths's Profit Margin Likely Faces 2Q Squeeze -- Market Talk

2026. g. 5. febr. 22:11 UTC

Peļņas

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9% -- Update

2026. g. 5. febr. 22:03 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 4th Update

2026. g. 5. febr. 22:01 UTC

Peļņas

Reddit Stock Jumps on Earnings. CFO Cites Modest AI Spending. -- Barrons.com

2026. g. 5. febr. 21:59 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

What's Next For Rio Tinto, Glencore After Deal Talks Fail? -- Market Talk

2026. g. 5. febr. 21:51 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Saylor's Strategy Posts $12 Billion Quarterly Loss on Bitcoin Selloff -- WSJ

2026. g. 5. febr. 21:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Basic Materials Roundup: Market Talk

2026. g. 5. febr. 21:49 UTC

Peļņas

Why Google's Bad News Was Good News for Broadcom and Nvidia -- Barrons.com

2026. g. 5. febr. 21:45 UTC

Peļņas

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9%

Salīdzinājums

Cenas izmaiņa

Integra LifeSciences Holdings Corp Prognoze

Cenas mērķis

By TipRanks

17.33% augšup

Prognoze 12 mēnešiem

Vidējais 13 USD  17.33%

Augstākais 13 USD

Zemākais 13 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Integra LifeSciences Holdings Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

3 ratings

0

Pirkt

3

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

12.75 / 16.41Atbalsts un pretestība

Īstermiņā

Strong Bearish Evidence

Vidējā termiņā

Strong Bearish Evidence

Ilgtermiņā

Weak Bearish Evidence

Noskaņojums

By Acuity

324 / 352 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat